Marlene

Marlene is a biotechnology company focused on developing a new class of programmable medicines. The company leverages RNA-guided systems to create highly specific and potent therapies designed to address a variety of diseases. Based in Cambridge, Massachusetts, Marlene is building a platform that utilizes the natural capabilities of RNA to guide therapeutic actions within cells. The company is currently in the pre-clinical stage and is backed by prominent venture capital firms, including ARCH Venture Partners. Founded by pioneers in the field of RNA biology and genome editing, Marlene aims to revolutionize how diseases are treated by providing precise, programmable control over molecular targets.